Source: Pharmaceutical Business Review

Vifor Pharma: NICE recommends Cara's Kapruvia to treat CKD-associated pruritus

Kapruvia has been recommenced to treat moderate-to-severe CKD-associated pruritus in adult patients who are undergoing haemodialysis. This will allow patients in Northern Ireland, England, and Wales to get The post NICE recommends Cara's Kapruvia to treat CKD-associated pruritus appeared first on Pharmaceutical Business review.

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Abbas Hussain's photo - CEO of Vifor Pharma

CEO

Abbas Hussain

CEO Approval Rating

83/100

Read more